Results 231 to 240 of about 79,600 (335)
Surrogate endpoints for new colorectal cancer drugs [PDF]
Meta-Analysis Group in Cancer
openalex +1 more source
The study presents biodegradable and recyclable mixed‐matrix membranes (MMMs), hydrogels, and cryogels using luminescent nanoscale metal‐organic frameworks (nMOFs) and biopolymers. These bio‐nMOF‐MMMs combine europium‐based nMOFs as probes for the status of the materials with the biopolymers agar and gelatine and present alternatives to conventional ...
Moritz Maxeiner +4 more
wiley +1 more source
Most matter is nominally frozen in the polar regions or space, and liquid crystal materials are no exception. Consequently, soft actuators, including liquid crystal elastomers (LCEs), are inoperative under such extreme cold in response to stimuli, as their motion relies on mechanical deformation.
Hyeonseong Kim +5 more
wiley +1 more source
Considerations for using potential surrogate endpoints in cancer screening trials. [PDF]
Webb AB +9 more
europepmc +1 more source
Next‐Generation Bio‐Reducible Lipids Enable Enhanced Vaccine Efficacy in Malaria and Primate Models
Structure–activity relationship (SAR) optimization of bio‐reducible ionizable lipids enables the development of highly effective lipid nanoparticle (LNP) mRNA vaccines. Lead LNPs show superior tolerability and antibody responses in rodents and primates, outperforming approved COVID‐19 vaccine lipids.
Ruben De Coen +30 more
wiley +1 more source
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials. [PDF]
Sherry AD +14 more
europepmc +1 more source
The first cryo‐EM visualization and quantification of oriented Photosystem I (PSI) on single‐layer graphene is reported. Domain‐specific covalent anchoring of PSI, with the reducing side of the biophotocatalyst toward graphene, promotes three‐fold higher anodic photocurrent generation compared to a randomly physisorbed counterpart. This approach allows
Miriam Izzo +6 more
wiley +1 more source
Optimal candidates and surrogate endpoints for HAIC versus Sorafenib in hepatocellular carcinoma: an updated systematic review and meta-analysis. [PDF]
Si T, Shao Q, Jassem W, Ma Y, Heaton N.
europepmc +1 more source

